© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 09, 2020
Balazs Halmos, MD, MS, discusses the importance of identifying biomarkers in advanced non–small cell lung cancer.
June 23, 2020
Balazs Halmos, MD, MS, discusses recent advancements made in non–small cell lung cancer.
November 12, 2019
Balazs Halmos, MD, MS, discusses actionable biomarkers in patients with oncogene-driven non–small cell lung cancer.
November 02, 2018
Balazs Halmos, MD, MS, director of thoracic oncology and director of clinical cancer genomics, Montefiore Medical Center, discusses second-line treatment for patients with metastatic squamous non–small cell lung cancer (NSCLC).